Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Rising geriatric population and chronic disease prevalence
3.2.1.2 Growing demand for neonatal and preterm enteral feeding
3.2.1.3 Increasing demand for enteral feeding in home care settings
3.2.1.4 Shifting trend toward consumption of disease-specific formulas
3.2.2 Industry pitfalls & challenges
3.2.2.1 High costs associated with enteral feeding
3.2.2.2 Risk of complications
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Technological landscape
3.5.1 Core technologies
3.5.2 Adjacent technologies
3.6 Pricing analysis
3.6.1 By region
3.6.2 By product
3.7 Consumer behavior analysis
3.8 Future market trends
3.9 Patent analysis
3.10 Pipeline analysis
3.11 Clinical trial landscape
3.12 Gap analysis
3.13 Porter’s analysis
3.14 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company market share analysis
4.3 Company matrix analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Product, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 Standard formulas
5.3 Disease specific formulas
5.4 Elemental formulas
5.5 Semi-elemental formulas
5.6 Other formulas
Chapter 6 Market Estimates and Forecast, By Stage, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 Adults
6.3 Pediatric
Chapter 7 Market Estimates and Forecast, By Application, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 Oncology
7.3 Gastrointestinal diseases
7.4 Neurological disorders
7.5 Diabetes
7.6 Critical care
7.7 Other applications
Chapter 8 Market Estimates and Forecast, By End Use, 2021 – 2032 ($ Mn)
8.1 Key trends
8.2 Hospitals
8.3 Long term care facilities
8.4 Home care settings
8.5 Nursing homes
Chapter 9 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)
9.1 Key trends
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 Spain
9.3.5 Italy
9.3.6 Netherlands
9.4 Asia Pacific
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Australia
9.4.5 South Korea
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Argentina
9.6 Middle East and Africa
9.6.1 South Africa
9.6.2 Saudi Arabia
9.6.3 UAE
Chapter 10 Company Profiles
10.1 Abbott Laboratories
10.2 B. Braun Melsungen AG
10.3 Baxter International
10.4 Danone S.A.
10.5 Fresenius Kabi
10.6 Functional Formularies
10.7 Hormel Health Labs
10.8 Kate Farms
10.9 Medtrition
10.10 Meiji Holdings
10.11 Nestlé
10.12 NutriMedical
10.13 Real Food Blends
10.14 Vegenat Healthcare
10.15 Victus
